秦川機牀(000837.SZ):擬投資10億元建高檔工業母機創新基地項目
格隆匯11月8日丨秦川機牀(000837.SZ)公佈,公司按照省委、省政府和省國資委加快推進秦創原建設的部署要求,圍繞“兩鏈”融合,整合產研優勢資源,於近日與陝西省西鹹新區開發建設管理委員會簽署投資協議,將在西鹹新區投資建設集科技研發、成果轉化和產業化於一體的高檔工業母機創新基地項目,計劃投資總額約10億元人民幣,項目用地面積約221畝。
公司此次擬投資建設的秦創原·秦川集團高檔工業母機創新基地項目,主要研發和生產高端五軸加工中心、高端通用數控系統、精密測量儀器、智能機牀、數字化製造中心及系統集成相關產品等。項目的實施將有助於企業實現產業升級,推動高質量發展,提升企業市場競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.